Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Astellas Pharma Inc
Neonc Technologies, Inc.
Cantargia AB
Nektar Therapeutics
Celgene